Exact Mass: 587.2453792
Exact Mass Matches: 587.2453792
Found 285 metabolites which its exact mass value is equals to given mass value 587.2453792
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
N-Acetyl-D-glucosaminyldiphosphodolichol
C23H43NO12P2 (587.2260378000001)
This compound is an intermediate in N-glycan biosynthesis, and the byproduct of N-acetylglucosaminyldiphosphodolichol (EC 2.4.1.141) and UDP-N-acetylglucosamine-dolichyl-phosphate (EC 2.7.8.15). (KEGG) This compound and its corresponding enzymes are implicated in the developmental programmes of a variety of eukaryotes. (PMID: 10024536) [HMDB] This compound is an intermediate in N-glycan biosynthesis, and the byproduct of N-acetylglucosaminyldiphosphodolichol (EC 2.4.1.141) and UDP-N-acetylglucosamine-dolichyl-phosphate (EC 2.7.8.15). (KEGG) This compound and its corresponding enzymes are implicated in the developmental programmes of a variety of eukaryotes. (PMID: 10024536).
7-(3-((3-Acetylphenoxy)methyl)-1,5-dimethyl-1H-pyrazol-4-yl)-3-(3-(naphthalen-1-yloxy)propyl)-1H-indole-2-carboxylic acid
Barasertib
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor
H-Gly-Arg-Gly-Asp-D-Ser-Pro-OH
GRGDSP, a synthetic linear RGD peptide, is an integrin inhibitor.
Nothramicin
An anthracycline antibiotic isolated from the culture broth of Nocardia sp. MJ896-43F17. It exhibits significant antimycobacterial activity against several drug-resistant Mycobacterium smegmatis strains.
7beta-hydroxy-6beta-(3,4,5-trimethoxybenzoyloxy)-3alpha-(E)-(3,4,5-trimethoxycinnamoyloxy)tropane
6-[2-ethoxy-2-(2,4,5-trimethoxyphenyl)]ethyl-7,8-dimethoxy-5-methyl-2,3-methylenedioxy-5,6-dihydrobenzo[c]phenanthridine|buesgeniine
3,10,11-triacetoxy-8beta-(4-acetoxybenzyl)-2-methoxyberbine|3,10,11-triacetoxy-8beta-<4-acetoxybenzyl>-2-methoxyberbine
Brominated Phosphatidylcholine C24H47BrNO8 - putative - Functions on the acyl moity have unknown location
Brominated Phosphatidylcholine mz 2+ C24H47BrNO8 - putative - Functions on the acyl moity have unknown location
Cys Phe Arg Tyr
Cys Phe Tyr Arg
Cys Arg Phe Tyr
Cys Arg Tyr Phe
Cys Tyr Phe Arg
Cys Tyr Arg Phe
Asp His Met Trp
Asp His Trp Met
Asp Lys Tyr Tyr
Asp Met His Trp
Asp Met Trp His
Asp Gln Tyr Tyr
Asp Trp His Met
Asp Trp Met His
Asp Tyr Lys Tyr
Asp Tyr Gln Tyr
Asp Tyr Tyr Lys
Asp Tyr Tyr Gln
Glu Phe His Arg
Glu Phe Arg His
Glu His Phe Arg
Glu His Arg Phe
Glu Asn Tyr Tyr
Glu Arg Phe His
Glu Arg His Phe
Glu Tyr Asn Tyr
Glu Tyr Tyr Asn
Phe Cys Arg Tyr
Phe Cys Tyr Arg
Phe Glu His Arg
Phe Glu Arg His
Phe Phe Phe Gln
Phe Phe Gln Phe
Phe His Glu Arg
Phe His Arg Glu
Phe His Val Trp
Phe His Trp Val
Phe Lys Met Tyr
Phe Lys Tyr Met
Phe Met Lys Tyr
Phe Met Gln Tyr
Phe Met Tyr Lys
Phe Met Tyr Gln
Phe Gln Phe Phe
Phe Gln Met Tyr
Phe Gln Tyr Met
Phe Arg Cys Tyr
Phe Arg Glu His
Phe Arg His Glu
Phe Arg Tyr Cys
Phe Val His Trp
Phe Val Trp His
Phe Trp His Val
Phe Trp Val His
Phe Tyr Cys Arg
Phe Tyr Lys Met
Phe Tyr Met Lys
Phe Tyr Met Gln
Phe Tyr Gln Met
Phe Tyr Arg Cys
Gly Trp Tyr Tyr
Gly Tyr Trp Tyr
Gly Tyr Tyr Trp
His Asp Met Trp
His Asp Trp Met
His Glu Phe Arg
His Glu Arg Phe
His Phe Glu Arg
His Phe Arg Glu
His Phe Val Trp
His Phe Trp Val
His Met Asp Trp
His Met Trp Asp
His Arg Glu Phe
His Arg Phe Glu
His Val Phe Trp
His Val Trp Phe
His Trp Asp Met
His Trp Phe Val
His Trp Met Asp
His Trp Val Phe
Lys Asp Tyr Tyr
Lys Phe Met Tyr
Lys Phe Tyr Met
Lys Met Phe Tyr
Lys Met Tyr Phe
Lys Tyr Asp Tyr
Lys Tyr Phe Met
Lys Tyr Met Phe
Lys Tyr Tyr Asp
Met Asp His Trp
Met Asp Trp His
Met Phe Lys Tyr
Met Phe Gln Tyr
Met Phe Tyr Lys
Met Phe Tyr Gln
Met His Asp Trp
Met His Trp Asp
Met Lys Phe Tyr
Met Lys Tyr Phe
Met Gln Phe Tyr
Met Gln Tyr Phe
Met Trp Asp His
Met Trp His Asp
Met Tyr Phe Lys
Met Tyr Phe Gln
Met Tyr Lys Phe
Met Tyr Gln Phe
Asn Glu Tyr Tyr
Asn Tyr Glu Tyr
Asn Tyr Tyr Glu
Gln Asp Tyr Tyr
Gln Phe Phe Phe
Gln Phe Met Tyr
Gln Phe Tyr Met
Gln Met Phe Tyr
Gln Met Tyr Phe
Gln Tyr Asp Tyr
Gln Tyr Phe Met
Gln Tyr Met Phe
Gln Tyr Tyr Asp
Arg Cys Phe Tyr
Arg Cys Tyr Phe
Arg Glu Phe His
Arg Glu His Phe
Arg Phe Cys Tyr
Arg Phe Glu His
Arg Phe His Glu
Arg Phe Tyr Cys
Arg His Glu Phe
Arg His Phe Glu
Arg Ser Tyr Tyr
C27H37N7O8 (587.2703482000001)
Arg Tyr Cys Phe
Arg Tyr Phe Cys
Arg Tyr Ser Tyr
C27H37N7O8 (587.2703482000001)
Arg Tyr Tyr Ser
C27H37N7O8 (587.2703482000001)
Ser Arg Tyr Tyr
C27H37N7O8 (587.2703482000001)
Ser Tyr Arg Tyr
C27H37N7O8 (587.2703482000001)
Ser Tyr Tyr Arg
C27H37N7O8 (587.2703482000001)
Val Phe His Trp
Val Phe Trp His
Val His Phe Trp
Val His Trp Phe
Val Trp Phe His
Val Trp His Phe
Trp Asp His Met
Trp Asp Met His
Trp Phe His Val
Trp Phe Val His
Trp Gly Tyr Tyr
Trp His Asp Met
Trp His Phe Val
Trp His Met Asp
Trp His Val Phe
Trp Met Asp His
Trp Met His Asp
Trp Val Phe His
Trp Val His Phe
Trp Tyr Gly Tyr
Trp Tyr Tyr Gly
Tyr Cys Phe Arg
Tyr Cys Arg Phe
Tyr Asp Lys Tyr
Tyr Asp Gln Tyr
Tyr Asp Tyr Lys
Tyr Asp Tyr Gln
Tyr Glu Asn Tyr
Tyr Glu Tyr Asn
Tyr Phe Cys Arg
Tyr Phe Lys Met
Tyr Phe Met Lys
Tyr Phe Met Gln
Tyr Phe Gln Met
Tyr Phe Arg Cys
Tyr Gly Trp Tyr
Tyr Gly Tyr Trp
Tyr Lys Asp Tyr
Tyr Lys Phe Met
Tyr Lys Met Phe
Tyr Lys Tyr Asp
Tyr Met Phe Lys
Tyr Met Phe Gln
Tyr Met Lys Phe
Tyr Met Gln Phe
Tyr Asn Glu Tyr
Tyr Asn Tyr Glu
Tyr Gln Asp Tyr
Tyr Gln Phe Met
Tyr Gln Met Phe
Tyr Gln Tyr Asp
Tyr Arg Cys Phe
Tyr Arg Phe Cys
Tyr Arg Ser Tyr
C27H37N7O8 (587.2703482000001)
Tyr Arg Tyr Ser
C27H37N7O8 (587.2703482000001)
Tyr Ser Arg Tyr
C27H37N7O8 (587.2703482000001)
Tyr Ser Tyr Arg
C27H37N7O8 (587.2703482000001)
Tyr Trp Gly Tyr
Tyr Trp Tyr Gly
Tyr Tyr Asp Lys
Tyr Tyr Asp Gln
Tyr Tyr Glu Asn
Tyr Tyr Gly Trp
Tyr Tyr Lys Asp
Tyr Tyr Asn Glu
Tyr Tyr Gln Asp
Tyr Tyr Arg Ser
C27H37N7O8 (587.2703482000001)
Tyr Tyr Ser Arg
C27H37N7O8 (587.2703482000001)
Tyr Tyr Trp Gly
N-Acetyl-D-glucosaminyldiphosphodolichol
C23H43NO12P2 (587.2260378000001)
SCH772984
SCH772984 is a highly selective and ATP-competitive ERK inhibitor, with IC50s of 4 and 1 nM for ERK1 and ERK2, respectively. SCH772984 has antitumor activity in MAPK inhibitor-na?ve and MAPK inhibitor-resistant cells containing BRAF or RAS mutations[1].
Aurora A Inhibitor I
2-[Ethyl[3-[[4-[[1-[2-[(3-fluorophenyl)amino]-2-oxoethyl]-1H-pyrazol-4-yl]amino]quinazolin-7-yl]oxy]propyl]amino]ethyl dihydrogen phosphate
5-O-(4,4-Dimethoxytrityl)-N4-acetyl-2-deoxycytidine
C32H33N3O8 (587.2267538000001)
3-Hexadecyl-1-methyl-1H-imidazolium 1,1,1-Trifluoro-N-[(trifluoromethyl)sulfonyl]methanesulfonamide
9-(Dimethylamino)-1-{4-[(2,5-dioxopyrrolidin-1-yl)oxy]-4-oxobutyl}-11,11-dimethyl-2,3,4,11-tetrahydronaphtho[2,3-g]quinolinium perchlorate
C29H34ClN3O8 (587.2034314000001)
3-({1-[3-Carbamimidoyl-1-(4-carbamimidoyl-benzylcarbamoyl)-propylcarbamoyl]-2-methyl-butylsulfamoyl}-methyl)-benzoic acid
[(2S)-1-oxo-1-[[(2S,10R,12S,14S)-12,16,19-trihydroxy-7,14,18-trimethoxy-6,17,21-trimethyl-5,8-dioxo-11,21-diazapentacyclo[11.7.1.02,11.04,9.015,20]henicosa-4(9),6,15(20),16,18-pentaen-10-yl]methylamino]propan-2-yl]azanium
Dinoflagellate luciferin(1-)
C33H39N4O6- (587.2869453999999)
The linear tetrapyrrole anion that is dinoflagellate luciferin protonated to pH 7.3.
(2R)-2-[(4R,5R)-4-methyl-5-[[methyl-[(4-phenoxyphenyl)methyl]amino]methyl]-1,1-dioxo-8-pyridin-4-yl-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
N-[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-2,5-dimethyl-3-pyrazolecarboxamide
C30H36F3N5O4 (587.2719251999999)
2-[(2R,4aS,12aS)-8-[[[(3,5-dimethyl-4-isoxazolyl)amino]-oxomethyl]amino]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-(5,6,7,8-tetrahydronaphthalen-2-yl)acetamide
N-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-2,5-dimethyl-3-pyrazolecarboxamide
C30H36F3N5O4 (587.2719251999999)
N-[(2S,3S)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-2,5-dimethyl-3-pyrazolecarboxamide
N-[(2R,3S)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-2,5-dimethyl-3-pyrazolecarboxamide
(2R)-2-[(4S,5R)-4-methyl-5-[[methyl-[(4-phenoxyphenyl)methyl]amino]methyl]-1,1-dioxo-8-pyridin-4-yl-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
N-[(2R,3R)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-2,5-dimethyl-3-pyrazolecarboxamide
N-[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-2,5-dimethyl-3-pyrazolecarboxamide
C30H36F3N5O4 (587.2719251999999)
(2S)-2-[(4S,5S)-4-methyl-5-[[methyl-[(4-phenoxyphenyl)methyl]amino]methyl]-1,1-dioxo-8-pyridin-4-yl-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
(2S)-2-[(4R,5S)-4-methyl-5-[[methyl-[(4-phenoxyphenyl)methyl]amino]methyl]-1,1-dioxo-8-pyridin-4-yl-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
(2S)-2-[(4S,5R)-4-methyl-5-[[methyl-[(4-phenoxyphenyl)methyl]amino]methyl]-1,1-dioxo-8-pyridin-4-yl-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
N-[(5S,6R,9R)-5-methoxy-3,6,9-trimethyl-8-(4-methylphenyl)sulfonyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-oxanecarboxamide
C30H41N3O7S (587.2665076000001)
2-amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-[(3-hydroxy-5-oxo-1,7-diphenylheptan-4-yl)sulfanyl]ethyl}-C-hydroxycarbonimidoyl)butanoic acid
C29H37N3O8S (587.2301242000001)
5-aminopentyl beta-D-glucopyranosyl-(1->3)-6-deoxy-2-O-methyl-alpha-L-talopyranosyl-(1->3)-beta-D-glucopyranoside
2-amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-[(2-hydroxy-5-oxo-1,7-diphenylheptyl)sulfanyl]ethyl}-C-hydroxycarbonimidoyl)butanoic acid
C29H37N3O8S (587.2301242000001)
2-amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-[(1-hydroxy-5-oxo-1,7-diphenylheptan-2-yl)sulfanyl]ethyl}-C-hydroxycarbonimidoyl)butanoic acid
C29H37N3O8S (587.2301242000001)
2-amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-[(4-hydroxy-5-oxo-1,7-diphenylheptan-3-yl)sulfanyl]ethyl}-C-hydroxycarbonimidoyl)butanoic acid
C29H37N3O8S (587.2301242000001)
2-amino-3-[[2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxy-3-hexanoyloxypropoxy]-hydroxyphosphoryl]oxypropanoic acid
2-amino-3-[[3-butanoyloxy-2-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid
3-[[3-acetyloxy-2-[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyl]oxypropoxy]-hydroxyphosphoryl]oxy-2-aminopropanoic acid
[3-hydroxy-2-[(Z)-16-(81Br)bromanyl-5-hydroxyhexadec-12-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
[3-hydroxy-2-[(Z)-16-(79Br)bromanyl-5-hydroxyhexadec-12-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
Barasertib
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor